Tokyo and New York-based private equity firm Wakabayashi Fund has agreed to provide funding to MIT Holding. No financial terms were disclosed. MIT is a wholesale distributor of pharmaceuticals.
SAVANNAH, GA–(Marketwired – Jan 14, 2014) – MIT Holding, Inc. (OTCQB: MITD) announces that it has entered into a funding agreement with Wakabayashi Fund LLC, a private equity firm based in Tokyo and New York.
Walter H.C. Drakeford, Co-CEO and Co-President of MIT, stated, “Bringing multiple funding sources to the table enables MIT to explore the best options available for the company. Wakabayashi offers unique funding sources that we believe will compliment the MIT expansion using an acquisition revenue growth strategy.”
Wakabayashi Fund, LLC is a private equity fund with offices in Tokyo, Japan and New York, which provides corporate capitalization and institutional investor relations consulting services. Wakabayashi Fund specializes in procuring capital for profitable and emerging small-cap and mid-cap companies, identifying institutional funding sources for its clients.
About MIT Holding, Inc.
Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT’s domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.
For more information, contact Mr. William Nalley, Orsay Groupe, email@example.com, phone 305-790-2688 and/or visit www.mitholdings.com.